Lemitias DT 25 Tablet
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Lamotrigine (25mg)
Overview Lemitias DT 25 Tablet
Epilepsy and bipolar disorder are effectively managed with Lemitias DT 25mg tablets, an anticonvulsant medication. Its mechanism involves interrupting brain signals responsible for seizures and stabilizing mood fluctuations. This medication can be administered alone or alongside other treatments, with or without food, as determined by your physician. Dosage may be gradually increased until your condition is controlled. While therapeutic effects may take several weeks, consistent use is crucial for optimal results. Discontinuing treatment without medical advice may exacerbate seizures or bipolar symptoms. Common side effects – including skin rashes, headaches, nausea, vomiting, insomnia, and dizziness – usually subside; however, persistent or bothersome effects require medical attention, especially skin rashes or peeling. Prolonged use might weaken bones (osteoporosis), increasing fracture risk. Prior to commencing treatment, inform your doctor of any kidney or liver issues, depression, suicidal ideation, or other medications you are taking, including contraceptives, as interactions may occur. Pregnant or breastfeeding individuals should discuss appropriate dosage adjustments. Avoid activities requiring alertness if drowsiness or dizziness occur. Regular blood tests monitor treatment effectiveness.
Uses of Lemitias DT 25 Tablet
Seizure disorders/Epilepsy; Bipolar affective disorder
Major Benefits of Lemitias DT 25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Always dissolve the Lemitias DT 25 Tablet in water before consumption. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Lemitias DT 25 Tablet:
- Skin rash
- Headache
- Nausea
- Vomiting
- Dryness in mouth
- Insomnia (difficulty in sleeping)
- Sleepiness
- Dizziness
- Back pain
- Abdominal pain
- Blurred vision
- Double vision
- Impaired coordination
- Nasal congestion (stuffy nose)
- Infection
How to use Lemitias DT 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Lemitias DT 25 Tablet in water before consumption. While it can be taken with or without food, consistency in timing is recommended.
How Lemitias DT 25 Tablet works:
Epileptic seizures are managed by Lemitias DT 25 Tablets, an anticonvulsant drug that reduces overactive brain neuron firing.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Lemitias DT 25 Tablets and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
The use of Lemitias DT 25 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible dangers prior to prescribing. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Using Lemitias DT 25 Tablet while breastfeeding appears to pose minimal risk. Available human data indicates negligible infant harm. Observe the infant for skin reactions, drowsiness, or feeding difficulties. Regular platelet counts and liver function tests are recommended.
DrivingUNSAFE
Driving ability may be impaired by Lemitias DT 25 Tablet, which can induce dizziness and diplopia.
KidneyCAUTION
Patients with kidney impairment should use Lemitias DT 25 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Lemitias DT 25 Tablets, as dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take Lemitias DT 25 Tablet :
Should you forget a Lemitias DT 25 Tablet dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Lemitias DT 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Triazine-Phenyl Derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Anticonvulsant sodium channel blockers |


